Nuzenio

Therapeutics Reports Positive

Therapeutics Reports Positive news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Definium Therapeutics reports $1.1B cash, $159.0M Q2 net loss and positive Phase 3 MDD topline - TradingViewTradingView · Thu, 06 Aug 2026 20:13:04 GMTLineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Business WireBusiness Wire · Thu, 06 Aug 2026 20:01:00 GMTIntellia Therapeutics reports Q2 2026 net loss of $106.6M, $628.4M cash; positive Phase 3 data for lonvo-z - TradingViewTradingView · Thu, 06 Aug 2026 11:53:01 GMTIntellia Therapeutics Reports Positive Phase 3 HAELO Data for Lonvo-z, Advances Nex-z Trials and Reaffirms Cash Runway Into 2028 - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTSeres Therapeutics reports positive trial resul... - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMTSpyre Therapeutics reports $1.145B cash, Q2 net loss $36.2M; positive Phase 2 induction data - TradingViewTradingView · Tue, 04 Aug 2026 20:13:01 GMTSilexion Therapeutics Reports New Positive Preclinical - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 13:15:00 GMTSilexion's SIL204 Alters Three Immune Pathways in Cancer Cells - Stock TitanStock Titan · Tue, 04 Aug 2026 13:15:00 GMT

Timeline

Thu, 06 Aug 2026 20:13:04 GMTDefinium Therapeutics reports $1.1B cash, $159.0M Q2 net loss and positive Phase 3 MDD topline - TradingView
Thu, 06 Aug 2026 20:01:00 GMTLineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
Thu, 06 Aug 2026 11:53:01 GMTIntellia Therapeutics reports Q2 2026 net loss of $106.6M, $628.4M cash; positive Phase 3 data for lonvo-z - TradingView
Thu, 06 Aug 2026 11:15:00 GMTIntellia Therapeutics Reports Positive Phase 3 HAELO Data for Lonvo-z, Advances Nex-z Trials and Reaffirms Cash Runway Into 2028 - Quiver Quantitative
Wed, 05 Aug 2026 07:00:00 GMTSeres Therapeutics reports positive trial resul... - Pluang
Tue, 04 Aug 2026 20:13:01 GMTSpyre Therapeutics reports $1.145B cash, Q2 net loss $36.2M; positive Phase 2 induction data - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Therapeutics Reports Positive.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.